![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 08, 2007 9:32:42 AM
A few thoughts on the following:
AXM Pharma Inc. a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese and other Asian markets, announced today that Brazil Wahsun Import & Export Ltd. has signed a ten-year agreement, under which AXM Pharma has been designated exclusive distributor for Sygen, a product which is produced by TRB Pharma of Brazil. Sygen measures pathological changes in the central nervous system and Parkinson's disease. AXM has entered into agreements with distributors from leading cities and provinces of Shanghai, Beijing, Guangdong, Jiangsu, Zhejiang and Shandong, to purchase a total quantity of 500,000 units, resulting in 2007 estimated revenue of $12,820,000
The fact that they are master distributor Brazil Wahsun and have entered into multiple agreements with other distributors, leads me to believe they have a nice distribution network set up to move other products they either are currently manufacturing or are intending to manufacture from their new plant.
It also seems that they have been busy with business while they were taking care of the SEC mishap. Now that thats behind, maybe we will see a stream of PR's having to do with moving forward.
I'm excited!!!
GLTA Checkmate28
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM